Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 19 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMAEXPRESS from Thimister-Clermont, company number BE0743800651, closed financial year 2025 with a result of € 162,647 after tax. For that financial year PHARMAEXPRESS recorded revenue of € 428,713 and equity of € 576,313. Compared with financial year 2024, the result moved from € 315,724 to € 162,647. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 28, 2026.
€ 576,313
▲ 39% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 162,647
▼ 48% vs 2024
Profit after tax over the fiscal year.
€ 460
▲ 125% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 76,313.
People and assets in 2025
2
▼ 1.7 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 210,447
▼ 51% vs 2024
€ 105,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 770
▼ 91% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 5,103
▼ 96% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 1,904,275 | € 816,656 | € 781,847 | € 428,713 | ▼ 45% |
| Gross margin | € 45,763 | € -10,792 | € 826,330 | € 399,381 | ▼ 52% |
| Profit after taxes | € -56,464 | € -120,942 | € 315,724 | € 162,647 | ▼ 48% |
| Equity | € 218,884 | € 97,942 | € 413,666 | € 576,313 | ▲ 39% |
| Total debts | € 163,540 | € 113,691 | € 140,911 | € 5,873 | ▼ 96% |
| Cash | € 22,569 | € 1,549 | € 204 | € 460 | ▲ 125% |
| Retained profit | € -281,116 | € -402,058 | € -86,334 | € 76,313 | ▲ € 162,647 |
| Balance sheet total | € 382,424 | € 211,633 | € 554,577 | € 582,187 | ▲ 5% |
| Employees (FTE) | 0.8 | 1.4 | 3.7 | 2 | ▼ 1.7 |
Key figures of PHARMAEXPRESS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMAEXPRESS?
What happened at PHARMAEXPRESS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 162,647 (▼ 48% vs 2024). Source: NBB ↗
- New establishment in Verviers. KBO
- Start of the company according to the CBE. KBO
- PIERRE LAFLEUR became a director. NBB
- SC PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT became a director. NBB
In short
From € 56,464 loss in 2022 to € 162,647 profit in 2025.
Paid € 33,103 in corporate taxes since 2022.
Best year ever: 2024, with € 315,724 profit.
On average € 199,700 of value added per employee in 2025.
A new publication or filing at PHARMAEXPRESS? We notify you, reason included.
Follow PHARMAEXPRESSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMAEXPRESSBehind PHARMAEXPRESS are PIERRE LAFLEUR and SC PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT. The shares are held by PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT (100%).
Directors
According to the 2025 annual accounts
since 2020
SC PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT
Director · represented by HELENE GORRIA
Also active at: La Grande Pharmacie, Pharmacie du Perron, PHARMACIE LARDINOIS, SANTIS PHARMA, SANTIS GROUP, Plate-Forme de Soins palliatifs de l'Est francophone, SOCIETE BEYNOISE DE PHARMACIE, V-IMMO +5 more
since 2020
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue de l'Avenir 12
4890 Thimister-Clermont
Rue de Mangombroux 161
4800 Verviers
Active since 18 February 2020
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.
All companies at this address →PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT same network
€ 109.5 million revenue · 2025
La Grande Pharmacie same network
€ 54,296 revenue · 2025
PHARMACIE LARDINOIS same network
€ 49,909 revenue · 2025
SANTIS PHARMA same network
€ 17.9 million revenue · 2025
GENERATION 2000
€ 971,059 revenue · 2025
+3 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
CYBERNET, BE
Website info
Features
Security
Details
- Company number
- 0743.800.651
- VAT number
- BE 0743.800.651
- Registered office
- Rue de l'Avenir 12, 4890 Thimister-Clermont
- Names & denominations
- PHARMAEXPRESS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 February 2020
- Peppol
- Active · Active since 10 Dec 2025
- Contact
- pharmaexpress.be [email protected]
- Activities · NACE
Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten
Computerconsultancy-activiteiten
Overige niet-gespecialiseerde detailhandel
Groothandel in farmaceutische en medische artikelen
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Vervaardiging van farmaceutische grondstoffen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels
+1